NDC Package 43835-0031-3 Semaglutide

Injection, Solution - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
43835-0031-3
Package Description:
1440 CONTAINER in 1 BOX / 1 SYRINGE, GLASS in 1 CONTAINER / .75 mL in 1 SYRINGE, GLASS
Product Code:
Non-Proprietary Name:
Semaglutide
Substance Name:
Semaglutide
Usage Information:
Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.
11-Digit NDC Billing Format:
43835003103
Product Type:
Drug For Further Processing
Labeler Name:
Catalent Belgium Sa
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Active Ingredient(s):
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
06-05-2021
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 43835-0031-3?

The NDC Packaged Code 43835-0031-3 is assigned to an UNFINISHED drug package of 1440 container in 1 box / 1 syringe, glass in 1 container / .75 ml in 1 syringe, glass of Semaglutide, drug for further processing labeled by Catalent Belgium Sa. The product's dosage form is injection, solution and is administered via form.

Is NDC 43835-0031 included in the NDC Directory?

Yes, Semaglutide is an UNFINISHED PRODUCT with code 43835-0031 that is active and included in the NDC Directory. The product was first marketed by Catalent Belgium Sa on June 05, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 43835-0031-3?

The 11-digit format is 43835003103. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-143835-0031-35-4-243835-0031-03